71 results on '"Hayden, Frederick G"'
Search Results
2. Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group
3. Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial
4. Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
5. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
6. Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
7. Global outbreak research: harmony not hegemony
8. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
9. Comment to: Baloxavir efficacy in North American Adults
10. A novel coronavirus outbreak of global health concern
11. Antivirals targeting the polymerase complex of influenza viruses
12. Macrolides in critically ill patients with Middle East Respiratory Syndrome
13. Ebola virus disease: an update on post-exposure prophylaxis
14. Serotherapy for patients with severe influenza
15. Current research on respiratory viral infections: Third International Symposium
16. The search for therapeutic options for Middle East Respiratory Syndrome (MERS)
17. Design, recruitment, and microbiological considerations in human challenge studies
18. Antiviral combinations for severe influenza
19. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options
20. Towards improving clinical management of Middle East respiratory syndrome coronavirus infection
21. Open source clinical science for emerging infections
22. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
23. Oseltamivir resistance during treatment of H7N9 infection
24. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
25. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count
26. Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials
27. Patient-oriented pandemic influenza research
28. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age
29. The Southeast Asian Influenza Clinical Research Network: Development and challenges for a new multilateral research endeavor
30. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus
31. Antivirals for influenza: Historical perspectives and lessons learned
32. Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection
33. Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model
34. Resistant influenza A viruses in children treated with oseltamivir: descriptive study
35. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing
36. Experimental rhinovirus challenges in adults with mild asthma: Response to infection in relation to IgE
37. Introduction: Emerging importance of the rhinovirus
38. Drug resistance and influenza pandemics
39. Drug resistance and influenza pandemics
40. Introduction: emerging importance of the rhinovirus
41. Influenza in the acute hospital setting
42. Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay
43. Influenza virus neuraminidase inhibitors: clinical aspects
44. Accumulation of segment 6 sgRNAs of influenza A viruses in the presence of neuraminidase inhibitors
45. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages
46. Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention
47. Current Research on Influenza and other Respiratory Viruses: II International Symposium
48. Influenza virus neuraminidase inhibitors
49. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
50. Performance of virus isolation and Directigen® Flu A to detect influenza A virus in experimental human infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.